Burden Shifted to Accused Infringer to Show Accused Product Not Made by Patented Process

Apr 6, 2017

Reading Time : 1 min

The court first considered the “substantial likelihood” prong, stating that the test was met by a “persuasive showing,” i.e., “less than . . . a preponderance of the evidence, but more than a slight possibility”. On balance, the court found the patentee’s evidence persuasive. The catalyst was shown to be present in the final product, and the accused infringer offered no explanation for this evidence. Furthermore, although less persuasive, the patentee adduced expert evidence stating that there was no commercially reasonable alternative processes by which to prepare the product. Finally, the alleged infringer’s evidence about the manufacturing process (conducted by a foreign corporation in a foreign country) suffered from “credibility issues,” and the alleged infringer also did not provide batch records.

Turning to the “reasonable effort” prong, the court stated that the test was met if the patentee followed “all of the avenues of discovery likely to uncover the [accused] process, including written discovery requests, facility inspections, first-hand observation of the process, independent testing of process samples, the use of experts, and depositions of the [appropriate] officials.” The court found that the patentee had made reasonable efforts by submitting several interrogatories and requests for production, following up on discovery responses to seek clarifications and further documentation, and taking the deposition of the appropriate corporate officer from the foreign manufacturing company. Given the “extremely difficult” circumstances that the patentee faced in trying to get evidence from the foreign manufacturer, not least because the alleged infringer did not fully cooperate in the discovery process, the court determined that the patentee’s efforts were reasonable.

Ultimately, the court denied the competing summary judgment motions on infringement because the quantity of catalyst used was still factually disputed. Nevertheless, the court shifted the burden to the alleged infringer to show at trial that the product was made by a non infringing process.

Syngenta Crop Protection, LLC v. Willowood, LLC, 1-15-cv-00274, 2017 WL 1133378 (M.D.N.C. Mar. 24, 2017, Order) (Eagles, J.)

Share This Insight

Previous Entries

IP Newsflash

December 18, 2025

The Federal Circuit recently vacated a $20 million jury verdict in favor of a patentee and remanded with instructions to dismiss the case for lack of subject matter jurisdiction, finding that the patentee did not own the asserted patents at the time it filed suit and therefore lacked standing.

...

Read More

IP Newsflash

December 17, 2025

The Federal Circuit recently affirmed a Patent Trial and Appeal Board decision finding claims that had been subject to an ex parte reexamination unpatentable. As a threshold issue, the court held that IPR estoppel under 35 USC § 315(e)(1) does not apply to ongoing ex parte reexaminations. Accordingly, the Patent Office did not err in continuing the reexamination after issuing final written decisions in co-pending IPRs.

...

Read More

IP Newsflash

December 15, 2025

The District of Delaware recently denied a defendant’s motion to dismiss plaintiff’s demand for enhanced damages based on willful infringement pursuant to 35 U.S.C. § 284, explaining that neither a demand for damages under § 284 nor an accusation of willful infringement amount to a claim for relief that can be subject to dismissal under Rule 12(b)(6).

...

Read More

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.